Shopping Cart
Remove All
Your shopping cart is currently empty
CAY10640 (sEH inhibitor-1) is a potent, orally active, water-soluble epoxide hydrolase (sEH) inhibitor that inhibits sEH in humans and mice with IC50s of 0.4 and 5.3 nM, respectively.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $125 | - | In Stock | |
| 5 mg | $312 | - | In Stock | |
| 10 mg | $459 | - | In Stock | |
| 25 mg | $691 | - | In Stock | |
| 50 mg | $980 | - | In Stock | |
| 100 mg | $1,310 | - | In Stock | |
| 200 mg | $1,770 | - | In Stock |
| Description | CAY10640 (sEH inhibitor-1) is a potent, orally active, water-soluble epoxide hydrolase (sEH) inhibitor that inhibits sEH in humans and mice with IC50s of 0.4 and 5.3 nM, respectively. |
| Targets&IC50 | sEH (mouse):0.4 nM |
| In vivo | Oral administration of 13 1-aryl-3-(1-acylpiperidin-4-yl)urea (CAY10640) inhibitors in mice revealed substantial improvements in pharmacokinetic parameters over previously reported 1-adamantylurea based inhibitors. This novel sEH inhibitor showed a 1000-fold increase in potency when compared to morphine by reducing hyperalgesia as measured by mechanical withdrawal threshold using the in vivo carrageenan induced inflammatory pain model.[1] |
| Synonyms | sEH inhibitor-1 |
| Molecular Weight | 371.35 |
| Formula | C17H20F3N3O3 |
| Cas No. | 1208549-68-1 |
| Smiles | C(=O)(C1CC1)N2CCC(NC(NC3=CC=C(OC(F)(F)F)C=C3)=O)CC2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMF: 4.5 mg/mL (12.12 mM), Sonication is recommended. Ethanol: 2 mg/mL (5.39 mM), Sonication is recommended. DMSO: 4.5 mg/mL (12.12 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
Ethanol/DMF/DMSO
DMF/DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.